This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

NEAL A. HALSEY, MD; MARY ANN WELLING, RN; ROBERT M. LEHMAN, MD

Am J Dis Child. 1980;134(5):521-522.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A variety of antimicrobial agents have been used to treat children with pertussis to decrease the excretion of Bordetella pertussis and we hope prevent transmission of the infection to other children.^1-5 Erythromycin is considered the drug of choice for B pertussis infections by the American See also p 520. Academy of Pediatrics Committee on Infectious Disease because of its low toxicity and superior efficacy in eradicating this organism from the nasopharynx when compared with other antimicrobial agents.^3-7

We report the failure of seven days of erythromycin therapy to eradicate B pertussis from the pharynx of an infant. A second infant who was exposed to this child also contracted pertussis in spite of prophylactic use of erythromycin.

Bacteriologic Methods.—Nasal washing specimens were cultured and examined by direct fluorescent antibody (FA) techniques. Fresh control slides were prepared for each FA examination using stock B pertussis and B parapertussis cultures. . . . [Full Text PDF of this Article]

Author Affiliations
Department of Pediatrics/C227 Children's Hospital and the University of Colorado Medical Center 4200 E Ninth Ave Denver, CO 80262

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?